BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Stock
Equities
2315
CNE100005D27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.72 CNY | -5.26% |
|
+11.60% | -18.86% |
| May. 06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2023 | 717M 99.33M | Sales 2024 * | 919M 127M | Capitalization | 3.58B 496M |
|---|---|---|---|---|---|
| Net income 2023 | -383M -53.06M | Net income 2024 * | -89M -12.33M | EV / Sales 2023 | 6.24 x |
| Net Debt 2023 | 126M 17.52M | Net Debt 2024 * | 133M 18.48M | EV / Sales 2024 * | 4.04 x |
| P/E ratio 2023 |
-11.3
x | P/E ratio 2024 * |
-40.8
x | Employees | 1,066 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 16.99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.26% | ||
| 1 week | +8.97% | ||
| Current month | +11.60% | ||
| 1 month | +37.68% | ||
| 3 months | +3.40% | ||
| 6 months | -23.10% | ||
| Current year | -18.86% |
1 week
8.61
10.60
1 month
5.7410.60
Current year
5.7412.02
1 year
5.7425.25
3 years
5.7428.80
5 years
5.7428.80
10 years
5.7428.80
| Managers | Title | Age | Since |
|---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | - | 09-11-12 |
Liu Bin
DFI | Director of Finance/CFO | - | 20-01-04 |
Sabrina Wang
COO | Chief Operating Officer | - | 19-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Feng Mao Hua
BRD | Director/Board Member | 56 | 21-06-30 |
Yi Liang Wei
BRD | Director/Board Member | 53 | - |
Xiao Yan Liang
BRD | Director/Board Member | 58 | 20-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 9.72 | -5.26% | 103,500 |
| 24-05-06 | 10.26 | +16.86% | 221,500 |
| 24-05-03 | 8.78 | -1.35% | 150,500 |
| 24-05-02 | 8.9 | +2.18% | 103,000 |
| 24-04-30 | 8.71 | -2.35% | 124,000 |
End-of-day quote Hong Kong S.E., May 06, 2024
More quotes
Biocytogen Pharmaceuticals Beijing Co Ltd is a China-based company mainly engaged in drug development business and preclinical research. The Company operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and model animal sales.
Calendar
2024-05-27
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.968
CNY
Average target price
14.21
CNY
Spread / Average Target
+58.49%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.86% | 524M | |
| +21.74% | 46.81B | |
| -0.97% | 41.37B | |
| +47.07% | 41.29B | |
| -3.52% | 28.87B | |
| +11.12% | 26.06B | |
| -19.37% | 19.13B | |
| +31.18% | 12.39B | |
| -0.04% | 12.08B | |
| +0.39% | 11.96B |
- Stock Market
- Equities
- 2315 Stock